ERVW-1 and renal cell carcinoma: In renal cell carcinoma (RCC), HERV-E is selectively expressed in cancer cells lacking the VHL tumor suppressor (195), and peptides derived from its envelope protein have been shown to bind HLA-A*0201 and stimulate patient-derived CD8+ T cells (196).